Let's find new treatments
together
Follow us

Our results since 2012

The French Foundation for Rare Diseases follows an active scientific policy and launches 5 to 7 calls for project proposals per year. Through these calls, the Foundation facilitates the access of researchers to cutting-edge technologies (high throughput sequencing platforms, molecular screening, and development of experimental models). Of the 975 projects received since 2012, 324 have been funded and are carried out by players involved in research and healthcare throughout France. The investment dedicated to these 324 projects by the FFRD amounts to 9,4 million euros.

Since 2012, 290 of the 324 funded projects funded have focused on the improved understanding of the causes and pathophysiological mechanisms underlying rare diseases and the development of novel treatments. The 34 other projects, funded by the CNSA, the DGS and the IRCEM Enterprise Foundation, support research in humanities and social sciences in the field of rare diseases, to improve the patients’ life path.

 

 

MISSION 1: DECYPHERING RARE DISEASES

 

 290 PROJECTS SUPPORTED WITH 15 PARTNER PLATFORMS

 

To help the diagnosis

  • 195 projects to identify the genes responsible

 

To develop new treatments

  • 95 projects to test therapeutic leads

 

 

 THE RESULTS OF THESE PROJECTS

 

To help the diagnosis

  • More than 60 new genes identified

 

To develop new treatments

  • nearly 60 animal models created
  • 88 therapeutic proofs of principle identified
  • 6 orphan drug designations obtained from the EMA
  • 15 connections with industrialists
  • 1 signed license agreement

 

 

MISSION 2: IMPROVING THE PATIENTS’ LIFE PATH

 

  • 34 funded projects bringing together doctors, researchers and patients’ associations
  • 117 research teams mobilized and 255 volunteer experts involved
  • 48 associations involved

 

6 SCIENTIFIC CONFERENCES